Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L01 ANTINEOPLASTIC AGENTS
      L01E PROTEIN KINASE INHIBITORS
        L01EA BCR-ABL tyrosine kinase inhibitors [DG:DG03161]
          L01EA01 Imatinib [DG:DG00710]
            D01441  Imatinib mesylate (USAN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Molecular Target Inhibitors
      Imatinib [DG:DG00710]
        D01441  Imatinib mesylate (USAN)

Therapeutic category of drugs in Japan [BR:br08301]
  4  Agents affecting cellular function
    42  Antineoplastics
      429  Miscellaneous
        4291  Other Antitumors
          D01441  Imatinib mesylate (USAN); Imatinib mesilate (JAN)

Drug groups [BR:br08330]
  Antineoplastic
    DG01918  Tyrosine kinase inhibitor
      DG03161  BCR-ABL inhibitor
        DG00710  Imatinib
          D01441  Imatinib mesylate
  Metabolizing enzyme substrate
    DG01633  CYP3A/CYP3A4 substrate
      DG02913  CYP3A4 substrate
        DG00710  Imatinib
          D01441  Imatinib mesylate

Drug classes [BR:br08332]
  Antineoplastic
    DG03161  BCR-ABL inhibitor
      D01441  Imatinib mesylate

Target-based classification of drugs [BR:br08310]
  Protein kinases
    Receptor tyrosine kinases (RTK)
      PDGFR family
        FIP1L1-PDGFRA [HSA:5156] [KO:K04363]
          D01441  Imatinib mesylate (USAN) <JP/US>
        KIT (CD117) [HSA:3815] [KO:K05091]
          D01441  Imatinib mesylate (USAN) <JP/US>
    Non-receptor tyrosine kinases
      ABL family
        BCR-ABL [HSA_VAR:25v1] [HSA:25] [KO:K06619]
          D01441  Imatinib mesylate (USAN) <JP/US>

New drug approvals in the USA [br08319.html]
  D01441

New drug approvals in Europe [br08329.html]
  D01441

New drug approvals in Japan [br08318.html]
  D01441

New drug approvals in the USA, Europe and Japan [br08328.html]
  D01441

Drug metabolizing enzymes and transporters [br08309.html]
  D01441

Pharmacogenomic biomarkers [br08341.html]
  D01441